Jay Sulzmann

🏛️ Revolving Door

Former Government Position:

Legislative Director/Health Policy Advisor, Sen. Johnny Isakson; Sr. Policy Advisor/LA/LC/SA, Rep. Wally Herger

Share:𝕏LinkedInFacebook
🤖

AI Overview

Jay Sulzmann has appeared in 1,163 federal lobbying filings at Penn Avenue Partners, representing 50 clients. As a former government official, they bring insider expertise to their lobbying work — part of Washington's "revolving door." Active across 37 policy areas.

1,163
Total Filings
1
Firms
50
Clients
37
Issue Areas

Issue Areas

TAXTOUTRDENGDEFLBRTECBUDHCRAVIPHANATAGRCSPACCFININSRETPOSTRACPTMMMAERIMMFOOCPIMANGOVMEDURBLAWGAMEDUTARRODENVHOU

Filing History

YearFilingsClients
202012622
202119128
202220532
202323632
202417630
202522932

Firms

Penn Avenue Partners1163 filings

Top Clients

Brighthouse Financial, INC.111 filings
Lockheed Martin Corporation64 filings
Exxon Mobil Corporation61 filings
Carnival Corporation57 filings
Unitedhealth Group, INC.57 filings
Palantir Technologies, INC.53 filings
Federal Express Corporation53 filings
Walmart INC51 filings
Comcast Corporation42 filings
General Dynamics Corporation41 filings
Ferrero USA, INC.39 filings
Nextera Energy, INC.39 filings
Tsmc Arizona39 filings
Hospice Action Network38 filings
Action Now Initiative, LLC37 filings
National Cable and Telecommunications Association33 filings
American Airlines, INC.33 filings
Alkermes, INC.26 filings
City of Weston Florida23 filings
Enbridge Energy Company, INC.21 filings

Related Analysis

🏛️ Revolving Door Premium
Do ex-government lobbyists earn more?
🕸️ Network Analysis
Explore connections between firms and lobbyists
🎯 Market Concentration
How concentrated is the lobbying market?

Related Investigations

The Revolving Door Exposed
How former government officials become the most powerful lobbyists.
The 22,000% ROI
When lobbying spending yields outsized returns.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Follow the Money
Tracking lobbying dollars through the financial system.

Explore More

← All Lobbyists🏛️ Revolving Door🕸️ Network Analysis🏛️ Agency Pressure 🔍 Investigations

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.